Drug Profile
Research programme: plant-derived cancer therapeutics - Unibioscreen
Alternative Names: UNBS 3078Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Unibioscreen
- Class
- Mechanism of Action Apoptosis stimulants; Cytoskeletal protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Cancer in Belgium
- 13 Sep 2007 Early research in Cancer in Belgium (unspecified route)